Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

HIV/AIDS. Report of novel treatment aimed at latent HIV raises the 'c word'.

Cohen J.

Science. 2005 Aug 12;309(5737):999-1000. No abstract available.

PMID:
16099956
[PubMed - indexed for MEDLINE]
2.

Anti-HIV agents. Valproic acid and HIV eradication--many questions remain.

[No authors listed]

TreatmentUpdate. 2005 Oct-Nov;17(6):5-7. No abstract available.

PMID:
17228476
[PubMed - indexed for MEDLINE]
3.

Valproic acid: a potential role in treating latent HIV infection.

Routy JP.

Lancet. 2005 Aug 13-19;366(9485):523-4. No abstract available.

PMID:
16099272
[PubMed - indexed for MEDLINE]
4.

Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection.

Archin NM, Cheema M, Parker D, Wiegand A, Bosch RJ, Coffin JM, Eron J, Cohen M, Margolis DM.

PLoS One. 2010 Feb 23;5(2):e9390. doi: 10.1371/journal.pone.0009390.

PMID:
20186346
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy.

Blazkova J, Chun TW, Belay BW, Murray D, Justement JS, Funk EK, Nelson A, Hallahan CW, Moir S, Wender PA, Fauci AS.

J Infect Dis. 2012 Sep 1;206(5):765-9. doi: 10.1093/infdis/jis412. Epub 2012 Jun 25.

PMID:
22732922
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The challenge of finding a cure for HIV infection.

Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ.

Science. 2009 Mar 6;323(5919):1304-7. doi: 10.1126/science.1165706. Review.

PMID:
19265012
[PubMed - indexed for MEDLINE]
7.

The emerging race to cure HIV infections.

Cohen J.

Science. 2011 May 13;332(6031):784-5, 787-9. doi: 10.1126/science.332.6031.784. No abstract available.

PMID:
21566173
[PubMed - indexed for MEDLINE]
8.

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.

Lehrman G, Hogue IB, Palmer S, Jennings C, Spina CA, Wiegand A, Landay AL, Coombs RW, Richman DD, Mellors JW, Coffin JM, Bosch RJ, Margolis DM.

Lancet. 2005 Aug 13-19;366(9485):549-55.

PMID:
16099290
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study.

Routy JP, Tremblay CL, Angel JB, Trottier B, Rouleau D, Baril JG, Harris M, Trottier S, Singer J, Chomont N, Sékaly RP, Boulassel MR.

HIV Med. 2012 May;13(5):291-6. doi: 10.1111/j.1468-1293.2011.00975.x. Epub 2012 Jan 26.

PMID:
22276680
[PubMed - indexed for MEDLINE]
10.

Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors.

Sahu GK, Cloyd MW.

Virol J. 2011 Aug 12;8:400. doi: 10.1186/1743-422X-8-400.

PMID:
21838863
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

HDAC inhibitors in HIV.

Wightman F, Ellenberg P, Churchill M, Lewin SR.

Immunol Cell Biol. 2012 Jan;90(1):47-54. doi: 10.1038/icb.2011.95. Epub 2011 Nov 15. Review.

PMID:
22083528
[PubMed - indexed for MEDLINE]
12.

Fusion inhibitors: T-20 and T-1249.

[No authors listed]

TreatmentUpdate. 2001 Spring;12(12):2-3. No abstract available.

PMID:
11570088
[PubMed - indexed for MEDLINE]
13.

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.

Archin NM, Liberty AL, Kashuba AD, Choudhary SK, Kuruc JD, Crooks AM, Parker DC, Anderson EM, Kearney MF, Strain MC, Richman DD, Hudgens MG, Bosch RJ, Coffin JM, Eron JJ, Hazuda DJ, Margolis DM.

Nature. 2012 Jul 25;487(7408):482-5. doi: 10.1038/nature11286. Erratum in: Nature. 2012 Sep 20;489(7416):460.

PMID:
22837004
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

HIV survives drug onslaught by hiding out in T cells.

Balter M.

Science. 1997 Nov 14;278(5341):1227. No abstract available.

PMID:
9411749
[PubMed - indexed for MEDLINE]
15.

No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.

Gandhi RT, Bosch RJ, Aga E, Albrecht M, Demeter LM, Dykes C, Bastow B, Para M, Lai J, Siliciano RF, Siliciano JD, Eron JJ; AIDS Clinical Trials Group A5173 Team.

J Infect Dis. 2010 Jan 15;201(2):293-6. doi: 10.1086/649569.

PMID:
20001856
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Katy, bar the door! HIV entry inhibitors.

Martinez LJ.

Res Initiat Treat Action. 2000 Jun;6(2):6-12. No abstract available.

PMID:
11707878
[PubMed - indexed for MEDLINE]
17.

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.

Chun TW, Justement JS, Moir S, Hallahan CW, Maenza J, Mullins JI, Collier AC, Corey L, Fauci AS.

J Infect Dis. 2007 Jun 15;195(12):1762-4. Epub 2007 May 2.

PMID:
17492591
[PubMed - indexed for MEDLINE]
Free Article
18.

Viral latency and potential eradication of HIV-1.

Matreyek KA, Oztop I, Freed EO, Engelman A.

Expert Rev Anti Infect Ther. 2012 Aug;10(8):855-7. doi: 10.1586/eri.12.68.

PMID:
23030323
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency.

Pérez M, de Vinuesa AG, Sanchez-Duffhues G, Marquez N, Bellido ML, Muñoz-Fernandez MA, Moreno S, Castor TP, Calzado MA, Muñoz E.

Curr HIV Res. 2010 Sep;8(6):418-29.

PMID:
20636281
[PubMed - indexed for MEDLINE]
20.

Can HIV infection be eradicated through use of potent antiviral agents?

Josefsson L, Dahl V, Palmer S.

Curr Opin Infect Dis. 2010 Dec;23(6):628-32. doi: 10.1097/QCO.0b013e32833ff1d0. Review.

PMID:
20847693
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk